Author Question: The most significant contribution to disproportionality in special education is: a. poverty b. ... (Read 50 times)

mpobi80

  • Hero Member
  • *****
  • Posts: 519
The most significant contribution to disproportionality in special education is:
 
  a. poverty
  b. SES
  c. race
  d. family income
  e. none of the above

Question 2

List three do's to make group contingencies work .
 
  What will be an ideal response?



bookworm410

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

C

Answer to Question 2

Use group reinforcement rather than a response cost.
Be sure that the behavior target and criteria are within the students' reach.
Include language loopholes that make the contingency easier to master and harder to sabotage.
Avoid language that implies an ultimatum, such as: If you don't do  , then I will do . Unless you do , we will not do .
Get a colleague to help you as you write your contingencies.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library